IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis

Journal of Interferon and Cytokine Research

Volumn 32, Issue 11, 2012, Pages 548-556

  Jin, Yu ^a   Lin, Yan ^a   Lin, Lianjie ^a   Zheng, Changqing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,6 TRINITROBENZENE SULFONIC ACID; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; COLITIS; CYTOKINES; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; INTESTINES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TRINITROBENZENESULFONIC ACID;

MUS;

EID: 84869020404     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0030     Document Type: Article

References (36)

1. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X. 2009. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 15(3):341-352.
2. Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K, and others. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455(7214):808-812.
3. Bai A, Guo Y, Lu N. 2007. The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand J Immunol 66(5):538-545. (Pubitemid 47609702)
4. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278(19):17036-17043. (Pubitemid 36799579)
5. Cremonini F, Talley NJ. 2005. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 34(4):189-204. (Pubitemid 40615950)
6. Damsker JM, Hansen AM, Caspi RR. 2010. Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183: 211-221.
7. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee Jr. 1999. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 189(8):1169-1180.
8. Fava F, Danese S. 2011. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 17(5): 557-566.
9. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156(1):5-7.
10. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B, Waisman A. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 119(1):61-69.
11. Hammerle CW, Surawicz CM. 2008. Updates on treatment of irritable bowel syndrome. World J Gastroenterol 14(17): 2639-2649.
12. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11): 1123-1132. (Pubitemid 41541790)
13. Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, Toyka KV, Gold R. 2005. Therapeutic efficacy of IL-17 neutralizationin murine experimental autoimmune encephalomyelitis. Cell Immunol 237(2):123-130. (Pubitemid 43117208)
14. Huang W, Na L, Fidel PL, Schwarzenberger P. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190(3):624-631. (Pubitemid 38982105)
15. Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR. 1997. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol 158(12):5997-6005. (Pubitemid 127484009)
16. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. 2004. IL-17 cytokine family. J Allergy Clin Immunol 114(6): 1265-1273. (Pubitemid 39585195)
17. Khan WI, Collins SM. 2006. Gut motor function: immunological control in enteric infection and inflammation. Clin Exp Immunol143(3):389-397.
18. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. 2000. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118(6):1001-1011. (Pubitemid 30346975)
19. Kolls JK, Linde'n A. 2004. Interleukin-17 family members and inflammation. Immunity 21(4):467-476. (Pubitemid 39370503)
20. Korn T, Oukka M, Kuchroo V, Bettelli E. 2007. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19(6):362-371. (Pubitemid 351274046)
21. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. 2005. IL- 23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233-240. (Pubitemid 40189432)
22. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203(10):2271-2279. (Pubitemid 44498362)
23. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205(4):799-810. (Pubitemid 351549879)
24. Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgamma. Nat Immunol 9(6):641-649. (Pubitemid 351714729)
25. Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Billiau A. 1998. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 28(7): 2143-2151. (Pubitemid 28321298)
26. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173. (Pubitemid 19138011)
27. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, and others. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152):480- 483. (Pubitemid 47123514)
28. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 110(1): 55-62. (Pubitemid 38177420)
29. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, and others. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133-1141. (Pubitemid 41541791)
30. Steinman L. 2008. A rush to judgment on Th17. J Exp Med 205(7):1517-1522. (Pubitemid 351962013)
31. Strober W, Fuss I, Mannon P. 2007. The fundamental basis of inflammatory bowel disease. J Clin Invest 117(3):514-521. (Pubitemid 46348505)
32. Ten Hove T, Corbaz A, Amitai H, Aloni S, Belzer I, Graber P, Drillenburg P, van Deventer SJ, Chvatchko Y, Te Velde AA. 2001. Blockade of endogenous IL-18 ameliorates TNBSinduced colitis by decreasing local TNF-alpha production in mice. Gastroenterology 121(6):1372-1379. (Pubitemid 33140454)
33. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V. 2008. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9(6):650-657. (Pubitemid 351712635)
34. Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427-434. (Pubitemid 47123518)
35. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454(7020):350-352.
36. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, and others. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194(4): 519-527. (Pubitemid 32835046)